HEXO Stock Price | HEXO Stock Quote, News, and History | Markets Insider (2024)

HEXO NewsMore News

Benzinga

Cash Flow Chronicles: Analyst Dissects Canadian Cannabis Balance Sheets, Market Trends Vs. The US

Benzinga

EXCLUSIVE: Key Insights And 4 Predictions On Cannabis Sector Equity Research For 2024

Benzinga

Tilray's HEXO Acquisition Creates Canada's Top Cannabis Company With 44% Market Share Boost

Tilray (NASDAQ: TLRY) is making bold moves to secure a profitable future, and its latest acquisition of HEXO Corp. (NASDAQ: HEXO) has solidified its position as Canada's top cannabis company with a 44% market share

Benzinga

HEXO Q3 FY23 Revenue Declines 11% QoQ And 53% YoY, Here Are The Details

HEXO Corp. (NASDAQ: HEXO) (TSX:HEXO) released its financial results for the third quarter of the 2023 fiscal year, revealing total net revenue of CA$21.6 million ($16.2 million), an 11% sequential decline.

HEXO Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
DateAnalystRatingPrice
06/16/23Capital DepescheMaintained Hold$1neutral

HEXO Estimates* in EUR

2024202520262027
Revenue----
Dividend----
Dividend Yield (in %)----
EPS----
P/E Ratio-2.26-3.67-1.60-2.05
EBIT----
EBITDA----
Net Profit----
Net Profit Adjusted----
Pre-Tax Profit----
Pre-Tax Profit Reported----
EPS (Non-GAAP) ex. SOE----
EPS (GAAP)----
Gross Income----
Cash Flow from Investing----
Cash Flow from Operations----
Cash Flow from Financing----
Cash Flow per Share----
Free Cash Flow----
Free Cash Flow per Share----
Book Value per Share----
Net Debt----
Research & Development Exp.----
Capital Expenditure----
Selling, General & Admin. Exp.----
Shareholder’s Equity----
Total Assets----

Income Statements in Mio. CAD

2022 2021 2020 2019 2018 2017 2016
Sales 191.10 123.77 80.78 47.54 4.93 4.10 0.00
Change of sales in % 54.40 53.21 69.92 863.55 20.43 - -
Gross profit on sales -164.11 -10.85 -97.34 -17.86 -2.60 0.19 0.00
Gross profit on sales change in % -1,412.83 88.86 -444.97 -586.98 - - -
Operating income -290.57 -94.95 -197.80 -125.83 -25.31 -7.15 -0.08
Operating income change in % -206.03 52.00 -57.20 -397.23 -254.10 - 63.79
Income before tax -1,103.26 -108.65 -546.18 -84.86 -23.35 -12.42 -0.08
Income before tax change in % -915.39 80.11 -543.65 -263.42 -88.04 - 63.79
Income after tax -1,067.59 -114.76 -546.49 -69.61 -23.35 -12.42 -0.08
Income after tax change in % -830.27 79.00 -685.10 -198.11 -88.04 - 63.79

Balance Sheet in Mio. CAD

2022 2021 2020 2019 2018 2017 2016
Total liabilities 367.26 579.54 136.19 89.91 12.12 23.74 0.01
Long-term liabilities per share 0.75 6.96 6.23 - 0.00 15.22 0.00
Equity 313.69 732.27 556.68 788.71 322.87 32.44 0.80
Equity change in % -57.04 31.99 -29.76 143.97 895.31 3,953.84 -8.89
Balance sheet total 680.95 1,311.80 692.87 878.62 335.00 56.18 0.81
Balance sheet total change in % -48.09 89.33 -21.14 162.28 496.30 - -11.98

Key Data in CAD

2022 2021 2020 2019 2018 2017 2016
Sales per share 6.88 13.61 14.62 0.22 2.06 3.92 0.00
P/E ratio (year end quote, basic EPS) - - - - - - -
P/E ratio (year end quote, diluted EPS) - - - - - - -
P/E ratio (year end quote) - - - - - - -
Dividend yield in % 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity ratio in % 46.07 55.82 80.34 89.77 96.38 57.74 98.58
Debt ratio in % 53.93 44.18 19.66 10.23 3.62 42.26 1.42

HEXO Dividend Calendar

Date Name Dividend *yield Currency
2022 HEXO Corp Registered Shs 0.00 0.00 CAD
2021 HEXO Corp Registered Shs 0.00 0.00 CAD
2020 HEXO Corp Registered Shs 0.00 0.00 CAD
2019 HEXO Corp Registered Shs 0.00 0.00 CAD
2018 HEXO Corp Registered Shs 0.00 0.00 CAD
2017 HEXO Corp Registered Shs 0.00 0.00 CAD
2016 HEXO Corp Registered Shs 0.00 0.00 CAD
2015 HEXO Corp Registered Shs 0.00 0.00 CAD
2014 HEXO Corp Registered Shs 0.00 - CAD

*Yield of the Respective Date

HEXO Calendar

Event Estimate Info Date

HEXO Past Events

Event Actual EPS Info Date

HEXO Profile

Hydropothecary is a licensed producer of medical marijuana under Health Canada’s Access to Cannabis for Medical Purposes Regulations.Their leadership team brings proven scientific, financial, regulatory and entrepreneurial expertise to the rapidly evolving Canadian medical marijuana industry.Hydropothecary is an award-winning medical cannabis producer located on a 143-acre farm in Gatineau, Quebec, in the National Capital Region. Their focus is on product innovation, advanced natural growing techniques, client health and safety, and exceptional customer service. They take their commitment to customers seriously, offering exceptional packaging, courier delivery in Canada (Saturdays where available) and their bilingual, 24-hour customer service.

HEXO Shareholder

Ownerin %
ETFMG Alternative Harvest ETF3.26
Global X Management Co. LLC2.84
Global X Cannabis ETF2.77
ETF Managers Group LLC2.75
William Todd Montour1.01
Peter James Montour1.01
Renaissance Technologies LLC0.79
Susquehanna Securities LLC0.60
Vincent Chiara0.59
Global X Marijuana Life Sciences Index ETF0.55

Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

HEXO Stock Price | HEXO Stock Quote, News, and History | Markets Insider (2024)

References

Top Articles
Latest Posts
Recommended Articles
Article information

Author: Ms. Lucile Johns

Last Updated:

Views: 5867

Rating: 4 / 5 (41 voted)

Reviews: 80% of readers found this page helpful

Author information

Name: Ms. Lucile Johns

Birthday: 1999-11-16

Address: Suite 237 56046 Walsh Coves, West Enid, VT 46557

Phone: +59115435987187

Job: Education Supervisor

Hobby: Genealogy, Stone skipping, Skydiving, Nordic skating, Couponing, Coloring, Gardening

Introduction: My name is Ms. Lucile Johns, I am a successful, friendly, friendly, homely, adventurous, handsome, delightful person who loves writing and wants to share my knowledge and understanding with you.